Citations

Showing 10 of 108162 citations.

Interobserver Agreement in Hepatitis C Grading and Staging and in the Banff Grading Schema for Acute Cellular Rejection: The “Hepatitis C 3” Multi-Institutional Trial Experience
Watkins, David L., Williams, James W., Colby, Thomas V. , Sharkey, Francis E. , Corless, Christopher L. , Lewin, David , Petrovic, Lydia, Kanel, Gary C., Theise, Neil D. , West, A. Brian, Koehler, Alison, Jhala, Nirag, Lefkowitch, Jay H., Lezzoni, Julia, Jennings, Linda W. , Tillery, G. Weldon, Klintmalm, Göran B. , Netto, George J. , Petris, Giovanni De , Sharma, Shobha

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 8 | Pages: 1157-1162

10.5858/2006-130-1157-iaihcg | PMID 16886238 Get It

Abstract Context. —Establishing adequate interobserver agreement is crucial not only for standardization of patient care but also to ensure validity of findings in multi-institutional trials. Objective. —To evaluate interobserver agreement in assessing chronic hepatitis C (HCV) and acute cellular rejection (ACR) among 17 hepatopathologists involved in the “Hepatitis C 3” trial. Design. —The trial is a randomized multicenter (17 institutions) study involving 312 patients undergoing transplantation for HCV. Patients are randomized to 3 treatment arms. For final data analysis, all biopsy specimens are reviewed by a central pathologist (G.J.N.). Recurrence of HCV is evaluated according to the Batts and Ludwig schema. The 1997 Banff schema is used to evaluate ACR. To assess interobserver agreement, hematoxylin-eosin–stained sections from 11 liver biopsy specimens (6 HCV and 5 ACR) were sent by the central pathologist to 16 local pathologists from 13 institutions. Statistical analysis was performed on raw ACR/HCV data as well as data grouped according to clinically significant primary endpoint cutoffs. Results. —Statistically significant agreement was found among all participating pathologists ( P < .001). On κ analysis, the degree of agreement was rated “moderate” for HCV grade and stage and ACR global grading (κ = 0.30, 0.33, and 0.37, respectively). Interobserver agreement was weaker for rejection activity index scoring of ACR (κ = 0.15). A stronger degree of agreement was found when scores were grouped based on endpoint cutoffs (κ = 0.76 “almost perfect” for HCV and 0.62 “substantial” for ACR). Conclusions. —An overall statistically significant interobserver agreement was found among 17 pathologists using the 1997 Banff schema and the Batts and Ludwig schema.
Imatinib Resistance: Obstacles and Opportunities
Litzow, Mark R.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 5 | Pages: 669-679

10.5858/2006-130-669-iroao | PMID 16683885 Get It

Abstract Objective. —To review the current status of resistance to imatinib mesylate (IM) in patients with chronic myelogenous leukemia, and the obstacles and opportunities presented by the development of this resistance. Data Sources and Study Selection. —Review of selected studies obtained from a MEDLINE search encompassing the years 1950 to 2004. Data Extraction and Data Synthesis. —Relevant information from the selected studies was abstracted and summarized. Conclusions. —The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy. An extensive search for molecules to block the aberrant BCR-ABL1 protein resulted in the development of IM as an orally bioavailable agent with remarkable efficacy in producing hematologic, cytogenetic, and molecular remissions. However, follow-up of patients treated with IM has demonstrated that some patients can develop resistance to IM with progression of their leukemia. Multiple mechanisms of resistance have been identified. The dominant mechanism appears to be mutations in the kinase domain of BCR-ABL1, which result in altered affinity of IM for the BCR-ABL1 protein. Recently, small-molecule, combined SRC and ABL1 inhibitors have been developed and entered into clinical trials. These inhibitors appear effective in inhibiting most of the mutant BCR-ABL1 molecules that are resistant to IM. The rapid development of new therapies for treatment of chronic myelogenous leukemia brings the promise that this disorder can be cured or controlled in many patients with oral drugs that have a low toxicity profile.
Error Reduction in Surgical Pathology
Nakhleh, Raouf E.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 5 | Pages: 630-632

10.5858/2006-130-630-erisp | PMID 16683877 Get It

Abstract Context. —Because of its complex nature, surgical pathology practice is inherently error prone. Currently, there is pressure to reduce errors in medicine, including pathology. Objective. —To review factors that contribute to errors and to discuss error-reduction strategies. Design. —Literature review. Results. —Multiple factors contribute to errors in medicine, including variable input, complexity, inconsistency, tight coupling, human intervention, time constraints, and a hierarchical culture. Strategies that may reduce errors include reducing reliance on memory, improving information access, error-proofing processes, decreasing reliance on vigilance, standardizing tasks and language, reducing the number of handoffs, simplifying processes, adjusting work schedules and environment, providing adequate training, and placing the correct people in the correct jobs. Conclusions. —Surgical pathology is a complex system with ample opportunity for error. Significant error reduction is unlikely to occur without a sustained comprehensive program of quality control and quality assurance. Incremental adoption of information technology and automation along with improved training in patient safety and quality management can help reduce errors.
A 75-Year-Old Man With an Asymptomatic Pleural-Based Mass Discovered on Routine Chest Radiographs
Qing, Gefei , Colby, Thomas V. , Leslie, Kevin O., Ionescu, Diana N.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 4 | Pages: e62-e65

10.5858/2006-130-e62-aymwaa | PMID 16594763 Get It

A novel rabbit thromboembolic occlusion model
Ding, Yong-Hong, Fitzgerald, Seán , Liu, Yang , Dai, Daying , Jakaitis, Daniel R. , Doyle, Karen , Brinjikji, Waleed , Kallmes, David F. , Kadirvel, Ramanathan , Jakaitis, Daniel, Savastano, Luis , Kadirvel, Ram , Fitzgerald, Seán , Dai, Daying , Liu, Yang , Ding, Yonghong

Mayo Clinic

Journal of NeuroInterventional Surgery | February 11, 2021 | Volume: 13 | Issue: 11 | Pages: 1040-1043

10.1136/neurintsurg-2020-017073 | PMID 33574137 Get It

Background To develop a preclinical thromboembolic occlusion model for studying revascularization strategies. Methods Clot analog with barium sulfate was injected into the distal aorta in 9 New Zealand white rabbits. The situation of aorta occlusion was compared among fibrin-rich (n=4), red blood cell (RBC)-rich (n=3), and whole blood clot analogs (n=2) using digital subtraction angiography. Arterial geometries, histologic features and circumferential stretch of the distal aorta in rabbits were compared with the common carotid artery in swine and the distal internal carotid artery (ICA) in humans. Aspiration thrombectomy and mechanical thrombectomy using a stent retriever were performed in two rabbits. Results The aortic bifurcation was occluded after a single delivery of clot in 4 cases. It was occluded after the second clot injection in the 5 remaining rabbits. Fragmentation of RBC-rich clots occurred during clot injection in 2 cases. The mean diameters of the distal aorta and right common iliac artery in rabbits were 3.7±0.4 and 2.8±0.3 mm, respectively; the mean diameters of human ICA, and first and second segments of the middle cerebral artery (M1, M2) were 3.6±0.4, 3.1±0.4, and 2.4±0.4 mm, respectively. Arterial revascularization was achieved in both rabbits. Geometric, mechanical and histological factors of the distal aorta in rabbit were more close to human distal ICA than swine carotid artery. Conclusion Arterial occlusion can be achieved at the aortic bifurcation in rabbits, which is comparable to human ICA bifurcation. This thrombectomy model has the potential to be used for testing of thrombectomy devices.
Carotid body chemoreceptors: physiology, pathology, and implications for health and disease
Iturriaga, Rodrigo , Alcayaga, Julio , Chapleau, Mark W. , Somers, Virend K.

Mayo Clinic

Physiological Reviews | February 11, 2021 | Volume: 101 | Issue: 3 | Pages: 1177-1235

10.1152/physrev.00039.2019 | PMID 33570461 Get It

The carotid body (CB) is the main peripheral chemoreceptor for arterial respiratory gases O 2 and CO 2 and pH, eliciting reflex ventilatory, cardiovascular, and humoral responses to maintain homeostasis. This review examines the fundamental biology underlying CB chemoreceptor function, its contribution to integrated physiological responses, and its role in maintaining health and potentiating disease. Emphasis is placed on 1) transduction mechanisms in chemoreceptor (type I) cells, highlighting the role played by the hypoxic inhibition of O 2 -dependent K + channels and mitochondrial oxidative metabolism, and their modification by intracellular molecules and other ion channels; 2) synaptic mechanisms linking type I cells and petrosal nerve terminals, focusing on the role played by the main proposed transmitters and modulatory gases, and the participation of glial cells in regulation of the chemosensory process; 3) integrated reflex responses to CB activation, emphasizing that the responses differ dramatically depending on the nature of the physiological, pathological, or environmental challenges, and the interactions of the chemoreceptor reflex with other reflexes in optimizing oxygen delivery to the tissues; and 4) the contribution of enhanced CB chemosensory discharge to autonomic and cardiorespiratory pathophysiology in obstructive sleep apnea, congestive heart failure, resistant hypertension, and metabolic diseases and how modulation of enhanced CB reactivity in disease conditions may attenuate pathophysiology.
Rotational Angiography-Based Gamma Knife Radiosurgery for Brain Arteriovenous Malformations: Preliminary Therapeutic Outcomes of the Novel Method
Shinya, Yuki , Shin, Masahiro , Kawashima, Mariko , Sugiyama, Takehiro , Ishikawa, Osamu , Koizumi, Satoshi , Suzuki, Yuichi , Saito, Nobuhito , Shinya, Yuki , Hasegawa, Hirotaka , Nakatomi, Hirofumi

Mayo Clinic

Neurosurgery | February 11, 2021 | Volume: 89 | Issue: 1 | Pages: 60-69

10.1093/neuros/nyab066 | PMID 33770182 Get It

Abstract BACKGROUND High-definition vascular imaging is desirable for treatment planning in Gamma Knife radiosurgery (GKRS; Elekta AB) for brain arteriovenous malformations (BAVMs). Currently, rotational angiography (RA) provides the clearest 3-dimensional visualization of niduses with high spatial resolution; however, its efficacy for GKRS has not been clarified. At our institution, RA has been integrated into GKRS (RA-GKRS) for better treatment planning and outcomes since 2015. OBJECTIVE To evaluate RA-GKRS outcomes of BAVMs and compare them with conventional GKRS (c-GKRS) outcomes. METHODS We retrospectively analyzed the radiosurgical outcomes of 50 BAVMs treated with RA-GKRS compared with the 306 BAVMs treated with c-GKRS. Considering possible differences in the baseline characteristics, we also created propensity score-matched cohorts and compared the radiosurgical outcomes between them to ensure comparability. RESULTS The obliteration time was shorter in the RA-GKRS group (cumulative rate, 88% vs 65% at 4 yr [ P = .001]). Multivariate Cox proportional hazards analysis demonstrated that the RA-GKRS group (hazard ratio 2.38, 95% CI 1.58-3.60; P = .001) had a better obliteration rate. The cumulative 4-yr post-GKRS hemorrhage rates were 4.0% and 2.6% in the RA-GKRS and c-GKRS groups, respectively ( P = .558). There was a trend toward early post-GKRS signal change in the RA-GKRS group compared with the c-GKRS group (cumulative rate, 38% vs 29% at 2 yr; P = .118). Those results were also confirmed in the matched cohort analyses. CONCLUSION The integration of RA into GKRS is promising and may provide earlier nidus obliteration.
Novel mapping techniques for rotor core detection using simulated intracardiac electrograms
Ravikumar, Vasanth , Annoni, Elizabeth M., Parthiban, Preethy , Zlochiver, Sharon, Roukoz, Henri , Mulpuru, Siva K. , Tolkacheva, Elena G. , Tolkacheva, E G , Zlochiver, Sharon

Mayo Clinic

Journal of Cardiovascular Electrophysiology | February 11, 2021 | Volume: 32 | Issue: 5 | Pages: 1268-1280

10.1111/jce.14948 | PMID 33570241 Get It

AbstractBackgroundCatheter ablation is associated with limited success rates in patients with persistent atrial fibrillation (AF). Currently, existing mapping systems fail to identify critical target sites for ablation. Recently, we proposed and validated several techniques (multiscale frequency [MSF], Shannon entropy [SE], kurtosis [Kt], and multiscale entropy [MSE]) to identify pivot point of rotors using ex‐vivo optical mapping animal experiments. However, the performance of these techniques is unclear for the clinically recorded intracardiac electrograms (EGMs), due to the different nature of the signals.ObjectiveThis study aims to evaluate the performance of MSF, MSE, SE, and Kt techniques to identify the pivot point of the rotor using unipolar and bipolar EGMs obtained from numerical simulations.MethodsStationary and meandering rotors were simulated in a 2D human atria. The performances of new approaches were quantified by comparing the “true” core of the rotor with the core identified by the techniques. Also, the performances of all techniques were evaluated in the presence of noise, scar, and for the case of the multielectrode multispline and grid catheters.ResultsOur results demonstrate that all the approaches are able to accurately identify the pivot point of both stationary and meandering rotors from both unipolar and bipolar EGMs. The presence of noise and scar tissue did not significantly affect the performance of the techniques. Finally, the core of the rotors was correctly identified for the case of multielectrode multispline and grid catheter simulations.ConclusionThe core of rotors can be successfully identified from EGMs using novel techniques; thus, providing motivation for future clinical implementations.
First-phase ejection fraction: association with remodelling and outcome in aortic valve stenosis
Carter‐Storch, Rasmus , Mogensen, Nils Sofus Borg , Christensen, Nicolaj Lyhne , Ali, Mulham , Laursen, K , Pellikka, Patricia A. , Dahl, Jordi S. , Dahl, Jordi S , Pellikka, Patricia A , Mortensen, Nils Sofus Borg , Carter-Storch, Rasmus , Møller, Jacob Eifer

Mayo Clinic

Open Heart | February 11, 2021 | Volume: 8 | Issue: 1 | Pages: e001543

10.1136/openhrt-2020-001543 | PMID 33574022 Get It

Background First-phase ejection fraction (EF1), the left ventricular (LV) ejection fraction (EF) until the time of peak transaortic velocity, is a novel marker of subclinical LV dysfunction able to predict adverse events in aortic stenosis (AS). This study investigated the association between end-systolic wall stress (ESWS) and EF1 in severe AS, as well as the prognostic value of EF1 in severe asymptomatic AS. Methods Two prospectively gathered cohorts of 94 asymptomatic patients and 108 symptomatic patients scheduled for aortic valve replacement (AVR), all with severe AS (aortic valve area <1 cm2) were stratified according to the median value of EF1 (33%). EF1 was defined as the EF at peak transaortic velocity. Asymptomatic patients were followed up for 3 years for the combined end-point of death, AVR or admission with heart failure. Results EF1 correlated with EF and was inversely associated with ESWS. In multivariate regression analysis, ESWS (p<0.001) and replacement fibrosis measured by MRI (p=0.02) were associated with EF1. Among asymptomatic patients, EF1 above the median was associated with the combined primary endpoint (HR=0.53 (95% CI 0.33 to 0.87)), while global longitudinal strain and EF were not. Among 42 patients with discordant AS (mean gradient <40 mm Hg), EF1 above median was associated with the primary endpoint (HR 0.28 (95% CI 0.12 to 0.61)). Conclusion EF1 is an afterload-dependent measure that is associated with events in patients with asymptomatic severe AS. The afterload dependency of EF1 may be useful in timing of risk stratification in patients with discordant AS. Trial registration numbers NCT02395107 and NCT02316587.
HER-2 Fluorescence In Situ Hybridization: Results From the Survey Program of the College of American Pathologists
Persons, Diane L., Tubbs, Raymond R., Cooley, Linda D. , Dewald, Gordon W., Dowling, Patricia K., Du, Emma, Mascarello, James T., Rao, Kathleen W., Wolff, Daynna J., Habegger-Vance, Gail, Wilson, Kathleen S.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 3 | Pages: 325-331

10.5858/2006-130-325-hfishr | PMID 16519559 Get It

Abstract Context. —Fluorescence in situ hybridization (FISH) is a common method used to determine HER-2 status in breast cancer. Limited information is available concerning reproducibility of FISH in determining HER-2 gene amplification. Objective. —To present proficiency testing results of FISH for HER-2 conducted by the Cytogenetics Resource Committee of the College of American Pathologists/American College of Medical Genetics. Design. —During the past 5 years, unstained sections from 9 invasive breast carcinomas were used for HER-2 FISH proficiency testing, allowing for comparison of FISH results among a large number of laboratories. Additional data were collected using an educational (ungraded) challenge and supplemental questions in the surveys. Results. —The number of laboratories participating in HER-2 FISH proficiency testing has increased steadily during the past 5 years (from 35 in 2000 to 139 in 2004). Reproducibility of test results among laboratories was excellent for breast tumors with low copy number (no HER-2 amplification) and for breast tumors with high copy number ( HER-2 amplification). However, there was considerable variation in interpretation of results for a tumor with low-level HER-2 amplification that was tested on 2 separate occasions. Responses to supplemental questions indicated that there was a need for consensus on the use of a separate equivocal/borderline interpretative category and the need for standardization of cutoff values used to define interpretative categories. Conclusions. —The College of American Pathologists proficiency survey programs provide useful information concerning the reproducibility of clinical testing for HER-2 by FISH and reflect clinical interpretation of HER-2 FISH analyses from laboratories across the country.